Saito, Rika
Kawamoto, Yasuyuki
Nishida, Mutsumi
Iwai, Takahito
Kikuchi, Yasuka
Yokota, Isao
Takagi, Ryo
Yamamura, Takahiro
Ito, Ken
Harada, Kazuaki
Yuki, Satoshi
Komatsu, Yoshito https://orcid.org/0000-0002-1570-6802
Sakamoto, Naoya
Article History
Received: 6 November 2021
Accepted: 8 August 2022
First Online: 30 August 2022
Declarations
:
: MN received a research grant from Nippon Shinyaku Co., Ltd. IY received grants from KAKENHI, AMED, Health, Labour and Welfare Policy Research Grants, Nihon Medi-Physics Co., Ltd., Chugai Pharmaceutical Co., Ltd., AstraZeneca Co., Ltd., Japan Tabacco Pharmaceutical Division Co., Ltd., Nippon Shinyaku Co., Ltd. NS received grants from Nihon Kayaku Co., Ltd., Bayer Co Ltd., Chugai Pharm Co., Ltd., Otsuka Pharm Co., Ltd., Gilead Sciences Co., Ltd., Astellas Co., Ltd. The other authors declare no conflicts of interest.